ScholarIQanswers from OpenAlex & ORCID
Gilles Salles
ResearcherPublications, citations & collaboration network
Gilles Salles is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Gilles Salles have?
ScholarIQindexed works
Gilles Salles has 1,728 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Gilles Salles have?
ScholarIQcitation count
Gilles Salles has 80,423 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Gilles Salles?
ScholarIQh-index
Gilles Salles has an h-index of 129 in OpenAlex.
What is the i10-index of Gilles Salles?
ScholarIQi10-index
Gilles Salles has an i10-index of 676 in OpenAlex.
What is the ORCID of Gilles Salles?
ScholarIQorcid
The ORCID for Gilles Salles is on the source record.
What is the OpenAlex record for Gilles Salles?
ScholarIQopenalex
The OpenAlex for Gilles Salles is on the source record.
What are the most-cited papers on Gilles Salles?
ScholarIQmost cited works
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial
Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond, Peter Mollee, Monica Sender, Petra Reinke, R. Neuhaus, H. Lehmkuhl, Heinz A. Horst, Gilles Salles, Franck Morschhauser, Arnaud Jaccard, Thierry Lamy, Malte Leithäuser, Heiner Zimmermann, Ioannis Anagnostopoulos, Martine Raphaël, Hanno Riess, Sylvain Choquet
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Franck Morschhauser, Nathan Fowler, Pierre Feugier, Réda Bouabdallah, Hervé Tilly, M. Lia Palomba, Christophe Fruchart, Edward N. Libby, Olivier Casasnovas, Ian W. Flinn, Corinne Haïoun, Hervé Maisonneuve, Loïc Ysebaert, Nancy L. Bartlett, Kamal Bouabdallah, Pauline Brice, Vincent Ribrag, Nicolas Daguindau, Steven Le Gouill, Gian M. Pica, Alejandro Martı́n, Armando López‐Guillermo, Jean-François Larouche, Kiyoshi Ando, María Gomes da Silva, Marc André, Pierre Zachée, Laurie H. Sehn, Kensei Tobinai, Guillaume Cartron, David Liu, Jianming Wang, Luc Xerri, Gilles Salles
Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
Maria Corinna Palanca-Wessels, Myron S. Czuczman, Gilles Salles, Sarit Assouline, Laurie H. Sehn, Ian W. Flinn, Manish R. Patel, Randeep Sangha, Anton Hagenbeek, Ranjana H. Advani, Hervé Tilly, Olivier Casasnovas, Oliver W. Press, Sreeni Yalamanchili, Robert S. Kahn, Randall Dere, Dan Lü, Surai Jones, Cheryl Jones, Yu-Waye Chu, Franck Morschhauser
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
Judith Trotman, Stefano Luminari, Sami Boussetta, Annibale Versari, Jehan Dupuis, Christelle Tychyj, Luigi Marcheselli, Alina Berriolo-Riedinger, Antonella Franceschetto, Anne Julian, Fabien Ricard, Luca Guerra, Corinne Haïoun, Irène Biasoli, Hervé Tilly, Massimo Federico, Gilles Salles, Michel Meignan